PDCD1 and neoplasm: To this end, MC38 tumor‐bearing mice were treated with low‐dose CPT‐11 for one week and then switched to anti‐PD‐1 antibody in the following week, or the two treatments were administered in the reverse order (Figure S2B, Supporting Information).